biostudies-literatureUnknown140(8)Heiblig MBlood927-931https://www.ebi.ac.uk/biostudies/studies/S-EPMC9412002biostudies-literatureRuxolitinib is more effective than other JAK inhibitors to treat VEXAS syndrome: a retrospective multicenter study.PMC9412002Bigot AGrayson PCGalland JBienvenu BFenaux PMekinian AVial GJamilloux YGalicier LSujobert PCoelho HBoutin ABWarrington KJGerfaud-Valentin MFossard GFerrada MAHeiblig MBeck DBLe Guenno GBarba TKermani TAPatel BAHirsch PKoster MJBarraco FfalseRuxolitinib is more effective than other JAK inhibitors to treat VEXAS syndrome: a retrospective multicenter study.2022-01-01T00:00:00Z2022 Aug2025-04-04T20:07:38.731Z2025-04-04T20:07:38.731ZS-EPMC94120023560917410.1182/blood.2022016642